Moderna: Jefferies maintains opinion on value

Moderna: Jefferies maintains opinion on value

Biogen: Jefferies maintains its rating on the title

Apple: Jefferies keeps its recommendation

Safran: Jefferies maintains its opinion

Walmart: Jefferies maintains opinion

Merck: Jefferies maintains its recommendation